Respiratory Health of Elite Athletes (cold air)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area.
Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be
- to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes.
- to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes
- to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.
| Condition |
|---|
|
Asthma Cardiovascular Diseases Metabolic Diseases |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Center of Excellence in CardioRespiratory Health of High-level Athletes: Evaluation of Long-term Effects of Training. |
Serum - plasma - sputum
| Enrollment: | 133 |
| Study Start Date: | June 2007 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Triathletes
|
|
2
Cold air athletes
|
|
3
Swimmers
|
|
4
Other sports elite athletes
|
|
5
Control subjects
|
Eligibility| Ages Eligible for Study: | 14 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Athletes training in the province of Quebec. Controls from Quebec schools and universities.
Inclusion Criteria:
- Athletes training more than 10 hours per week-
Exclusion Criteria:
- asthma or other pathologies that may interfere with the study
- Smokers
- Obese of with a BMI more than 29
Contacts and Locations| Canada | |
| Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec | |
| Quebec, Canada, G1V4G5 | |
| Principal Investigator: | Paul POIRIER, MD | Hôpital LAval |
More Information
No publications provided by Laval University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dr Louis-Philippe BOULET, Institut universitaire de cardiologie et de pneumologie de Québec |
| ClinicalTrials.gov Identifier: | NCT00686491 History of Changes |
| Other Study ID Numbers: | CER 20141 |
| Study First Received: | May 26, 2008 |
| Last Updated: | February 21, 2011 |
| Health Authority: | Canada: Canadian Institutes of Health Research |
Keywords provided by Laval University:
|
Asthma Environment Type of sport Cardiovascular disease Athletes |
Additional relevant MeSH terms:
|
Asthma Cardiovascular Diseases Metabolic Diseases Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive |
Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013